openPR Logo
Press release

Dravet Syndrome Treatment Market to Witness Stunning Growth | Biocodex, Epygenix Therapeutics, GW Pharmaceuticals

04-10-2023 02:03 PM CET | Health & Medicine

Press release from: HTF Market Intelligence Consulting Private Limited

Dravet Syndrome Treatment

Dravet Syndrome Treatment

HTF Market Intelligence published a new research publication on Dravet Syndrome Treatment Market Insights, to 2028" with 150+pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Dravet Syndrome Treatment market was mainly driven by the increasing R&D spending across the world, however latest scenario and economic slowdown have changed complete market dynamics. Some of the key players profiled in the study are Biocodex (United Kingdom), Epygenix Therapeutics, Inc. (United States), GW Pharmaceuticals Plc. (United Kingdom), Ovid Therapeutics (United States), Takeda Pharmaceutical Company Ltd (Japan), OPKO Health Inc. (United States), Zogenix, Inc. (United States), PTC Therapeutics, Inc. (United States), Biscayne Neurotherapeutics, Inc. (Supernus Pharmaceuticals) (United States), Pfizer Inc. (United States)

Get an Inside Scoop of Study, Request now for Sample Study @ https://www.htfmarketintelligence.com/sample-report/global-dravet-syndrome-treatment-market

According to HTF Market Intelligence, the Global Dravet Syndrome Treatment market to witness a CAGR of 8.2% during forecast period of 2023-2028. The market is segmented by Global Dravet Syndrome Treatment Market Breakdown by Application (Hospital Pharmacy, Retail Pharmacy, E- Commerce, Others) by Type (First-generation Drug (FGD), Second-generation Drug (SGD), Third-generation Drug (TGD)) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Dravet Syndrome Treatment market size is estimated to increase by USD 299.5 Million at a CAGR of 8.2% from 2023 to 2028. The report includes historic market data from 2017 to 2022E. Currently, market value is pegged at USD 493.8 Million.

Definition:
Dravet syndrome treatment market refers to the market for therapies, drugs, and other treatments that are used to manage Dravet syndrome, a rare and severe form of epilepsy that usually begins in infancy. Dravet syndrome is a genetic disorder that causes seizures that are often difficult to control with standard epilepsy medications.

The titled segments and sub-section of the market are illuminated below:
The Study Explore the Product Types of Dravet Syndrome Treatment Market: First-generation Drug (FGD), Second-generation Drug (SGD), Third-generation Drug (TGD)

Key Applications/end-users of Dravet Syndrome Treatment Market: Hospital Pharmacy, Retail Pharmacy, E- Commerce, Others

Market Trends:
Strong Drug Pipeline for the Treatment

Market Drivers:
Rising Number of Treatment Strategies

Market Opportunities:
Highly Focused Innovation in Product Technologies

Book Latest Edition of Global Dravet Syndrome Treatment Market Study @ https://www.htfmarketintelligence.com/buy-now?format=1&report=294

With this report you will learn:
• Who the leading players are in Dravet Syndrome Treatment Market?
• What you should look for in a Dravet Syndrome Treatment
• What trends are driving the Market
• About the changing market behaviour over time with strategic view point to examine competition
Also included in the study are profiles of 15 Dravet Syndrome Treatment vendors, pricing charts, financial outlook, swot analysis, products specification &comparisons matrix with recommended steps for evaluating and determining latest product/service offering.

List of players profiled in this report: Biocodex (United Kingdom), Epygenix Therapeutics, Inc. (United States), GW Pharmaceuticals Plc. (United Kingdom), Ovid Therapeutics (United States), Takeda Pharmaceutical Company Ltd (Japan), OPKO Health Inc. (United States), Zogenix, Inc. (United States), PTC Therapeutics, Inc. (United States), Biscayne Neurotherapeutics, Inc. (Supernus Pharmaceuticals) (United States), Pfizer Inc. (United States)

Who should get most benefit of this report?
• Anyone who are directly or indirectly involved in value chain cycle of this industry and needs to be up to speed on the key players and major trends in the market for Dravet Syndrome Treatment
• Marketers and agencies doing their due diligence in selecting a Dravet Syndrome Treatment for large and enterprise level organizations
• Analysts and vendors looking for current intelligence about this dynamic marketplace.
• Competition who would like to benchmark and correlate themselves with market position and standings in current scenario.

Make an enquiry to understand outline of study and further possible customization in offering https://www.htfmarketintelligence.com/enquiry-before-buy/global-dravet-syndrome-treatment-market

Quick Snapshot and Extracts from TOC of Latest Edition
Overview of Dravet Syndrome Treatment Market
Dravet Syndrome Treatment Size (Sales Volume) Comparison by Type (First-generation Drug (FGD), Second-generation Drug (SGD), Third-generation Drug (TGD))
Dravet Syndrome Treatment Size (Consumption) and Market Share Comparison by Application (Hospital Pharmacy, Retail Pharmacy, E- Commerce, Others) (2022-2028)
Dravet Syndrome Treatment Size (Value) Comparison by Region (2023-2028)
Dravet Syndrome Treatment Sales, Revenue and Growth Rate (2023-2028)
Dravet Syndrome Treatment Competitive Situation and Current Scenario Analysis
Strategic proposal for estimating sizing of core business segments
Players/Suppliers High Performance Pigments Manufacturing Base Distribution, Sales Area, Product Type (First-generation Drug (FGD), Second-generation Drug (SGD), Third-generation Drug (TGD))
Analyse competitors, including all important parameters of Dravet Syndrome Treatment
Dravet Syndrome Treatment Manufacturing Cost Analysis
Latest innovative headway and supply chain pattern mapping of leading and merging industry players

Get Detailed TOC and Overview of Report @
https://www.htfmarketintelligence.com/report/global-dravet-syndrome-treatment-market

Actual Numbers & In-Depth Analysis of Global Dravet Syndrome Treatment Market Size Estimation and Trends Available in Full Version of the Report.

Thanks for reading this article, you can also make sectional purchase or opt-in for regional report by limiting the scope to only North America, ANZ, Europe or MENA Countries, Eastern Europe or European Union.

Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Phone: +1 434 322 0091
sales@htfmarketintelligence.com

About Author:
HTF Market Intelligence Consulting is uniquely positioned to empower and inspire with research and consulting services to empower businesses with growth strategies, by offering services with extraordinary depth and breadth of thought leadership, research, tools, events, and experience that assist in decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dravet Syndrome Treatment Market to Witness Stunning Growth | Biocodex, Epygenix Therapeutics, GW Pharmaceuticals here

News-ID: 3005999 • Views:

More Releases from HTF Market Intelligence Consulting Private Limited

Linen Fabric Market Hits New High | Major Giants LinenMe, Libeco, H&M
Linen Fabric Market Hits New High | Major Giants LinenMe, Libeco, H&M
HTF MI just released the Global Linen Fabric Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Key Players in This Report Include: LinenMe, Libeco, H&M, IKEA, Towels, Ralph
Hosiery Market Hits New High | Major Giants Jockey, Fruit of the Loom, Peds
Hosiery Market Hits New High | Major Giants Jockey, Fruit of the Loom, Peds
HTF MI just released the Global Hosiery Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Key Players in This Report Include: Hanesbrands, Calvin Klein, Nike, Adidas, L'eggs, Burlington,
Aquaculture Market Is Going to Boom| Regal Springs, AquaStar, Best Aquaculture Practices.
Aquaculture Market Is Going to Boom| Regal Springs, AquaStar, Best Aquaculture P …
HTF MI just released the Global Aquaculture Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Key Players in This Report Include: Marine Harvest, Thai Union Group, Mowi, Leroy
C5ISR Market Is Booming So Rapidly Major Giants | Viasat, Textron
C5ISR Market Is Booming So Rapidly Major Giants | Viasat, Textron
HTF MI just released the Global C5ISR Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Key Players in This Report Include: Lockheed Martin, Northrop Grumman, Raytheon Technologies, General

All 5 Releases


More Releases for Dravet

Dravet Syndrome Market Forecast 2025-2034: Comprehensive Analysis And Growth Opp …
"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Projected Growth of the Dravet Syndrome Market? There has been significant growth in the Dravet Syndrome market size in the preceding years. Forecasted to expand from $0.37 billion in 2024 to $0.40 billion in 2025, this robust growth signifies a compound annual growth rate (CAGR) of 9.0%. This monumental
Dravet Syndrome Market Poised for Growth with New Treatment Advances 2034
The Dravet Syndrome Market Is Set To Grow At An Estimated CAGR Of 7.3% From 2025 To 2034, Rising From $1.3 Billion In 2024 To $2.5 Billion By 2034. On March 20, 2025, Exactitude Consultancy., Ltd. released a research report titled Dravet Syndrome Market 2025-2034 This report offers a new perspective on the Dravet Syndrome Market covering an extensive range of aspects including market overview, expenditure analysis, import trends, segmentation, key
Dravet Syndrome Treatment Market Is Booming Worldwide | Biocodex, Zogenix, Pfize …
The "Dravet Syndrome Treatment Market" intelligence report, just published by USD Analytics Market, covers a micro-level study of important market niches, product offers, and sales channels. to determine market size, potential, growth trends, and competitive environment, the Dravet Syndrome Treatment Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the
Dravet Syndrome Market Size, Share And Growth Analysis For 2023-2032
"According to the research report, the global dravet syndrome market was valued at USD 227.72 million in 2022 and is expected to reach USD 557.17 million by 2032, to grow at a CAGR of 9.4% during the forecast period." Get Sample with Latest Trends and Future Advancements @ https://www.polarismarketresearch.com/industry-analysis/dravet-syndrome-market/request-for-sample Polaris Market Research has recently published its latest analysis on Dravet Syndrome Market 2023: By Types, Applications, Size, Share, Key Players & Regions
Dravet Syndrome Treatment Market Overview
Dravet syndrome, also known as severe myoclonic epilepsy of infancy (SMEI), is a rare and debilitating neurological disorder that primarily affects infants and young children. It is characterized by recurrent, prolonged seizures that are often resistant to conventional antiepileptic medications. Additionally, individuals with Dravet syndrome may experience developmental delays, cognitive impairment, behavioral issues, and other associated health challenges. The rarity of Dravet syndrome, with an estimated prevalence of approximately 1 in
Dravet Syndrome Treatment Market to Increase Exponentially During 2028
Coherent Market Insights report on the Dravet Syndrome Treatment Market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2021 to 2028. The report provides the overall market value of the Dravet Syndrome Treatment Market for the period of 2021 to 2028, with 2020 as the base year and 2028 as the forecast